Abeona Therapeutics Company
Abeona Therapeutics develops gene therapy-based potential cures for Sanfilippo syndrome types A and B.
Technology:
Cell-based gene therapy, Others
Industry:
Gene Therapy, Public
Headquarters:
New York, New York, United States
Founded Date:
1989-01-01
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
13
Total Funding:
309700000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-11-03
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership